Karma Biotechnologies Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Karma Biotechnologies's estimated annual revenue is currently $2.5M per year.(i)
  • Karma Biotechnologies's estimated revenue per employee is $155,000

Employee Data

  • Karma Biotechnologies has 16 Employees.(i)
  • Karma Biotechnologies grew their employee count by -6% last year.

Karma Biotechnologies's People

NameTitleEmail/Phone
1
Cofounder and CEOReveal Email/Phone
2
President, Chief Financial Officer & Chief Business OfficerReveal Email/Phone
3
Associate DirectorReveal Email/Phone
4
Associate DirectorReveal Email/Phone
5
Principal ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Karma Biotechnologies?

Therapies for autoimmune diseases are stuck in the 20th century – physicians can only alleviate a patient's symptoms by crippling their entire immune system. Karma was founded by a team of immune engineers, nanotech scientists, and company builders to create a better solution. We're developing Xavines™, off-the-shelf therapeutics designed to shut down only the self-attacking rogue immune cells while leaving the rest of the immune system functional.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A16-6%N/A
#2
$3.1M16-6%N/A
#3
$1.4M16N/AN/A
#4
$1.4M16N/AN/A
#5
$1.4M16N/AN/A